{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:21:49Z","timestamp":1719966109089},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,2]]},"DOI":"10.7759\/cureus.63658","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T11:57:40Z","timestamp":1719921460000},"source":"Crossref","is-referenced-by-count":0,"title":["A Comparative Study of Novel Fibrosis Index and Other Non-invasive Serum Indices for Predicting Fibrosis in Patients of Chronic Liver Disease"],"prefix":"10.7759","author":[{"given":"Kaustubh","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahak","family":"Lamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pahul","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. K","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himanshu","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Patwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Rungta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Chronic liver disease","author":"Sharma A","year":"2024","unstructured":"Sharma A, Nagalli S. Chronic liver disease. StatPearls [Internet]. StatPearls Publishing, Treasure Island; 2024."},{"key":"ref2","article-title":"Non-invasive assessment of liver fibrosis","volume":"25","author":"Papastergiou V","year":"2012","unstructured":"Papastergiou V, Tsochatzis E, Burroughs AK. Non-invasive assessment of liver fibrosis. Ann Gastroenterol. 2012, 25:218-31.","journal-title":"Ann Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2019-000316","article-title":"Validation of Novel Fibrosis Index (NFI) for assessment of liver fibrosis: comparison with transient elastography (FibroScan)","volume":"6","author":"Hussain A","year":"2019","unstructured":"Hussain A, Gul MA, Khalid MU. Validation of Novel Fibrosis Index (NFI) for assessment of liver fibrosis: comparison with transient elastography (FibroScan). BMJ Open Gastroenterol. 2019, 6:e000316. 10.1136\/bmjgast-2019-000316","journal-title":"BMJ Open Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24624","article-title":"Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients","volume":"55","author":"Myers RP","year":"2012","unstructured":"Myers RP, Pomier-Layrargues G, Kirsch R, et al.. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology. 2012, 55:199-208. 10.1002\/hep.24624","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure","volume":"66","author":"Wendon","year":"2017","unstructured":"Wendon, J, Cordoba J, Dhawan A, et al.. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017, 66:1047-81. 10.1016\/j.jhep.2016.12.003","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018, 69:406-60. 10.1016\/j.jhep.2018.03.024","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20506","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C","volume":"41","author":"Ziol M","year":"2005","unstructured":"Ziol M, Handra-Luca A, Kettaneh A, et al.. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005, 41:48-54. 10.1002\/hep.20506","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"10","author":"Zweig MH","year":"1993","unstructured":"Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993, 10:561-77. 10.1093\/clinchem\/39.4.561","journal-title":"Clin Chem"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/ijot.ijot_27_19","article-title":"Incidence and risk factors for mortality in patients with cirrhosis awaiting liver transplantation","volume":"13","author":"Jain M","year":"2019","unstructured":"Jain M, Varghese J, Kedarishetty CK, Srinivasan V, Venkataraman J. Incidence and risk factors for mortality in patients with cirrhosis awaiting liver transplantation. Ind J Transplant. 2019, 13:210-5. 10.4103\/ijot.ijot_27_19","journal-title":"Ind J Transplant"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40139-014-0061-z","article-title":"Noninvasive biomarkers of liver fibrosis: clinical applications and future directions","volume":"2","author":"Motola DL","year":"2014","unstructured":"Motola DL, Caravan P, Chung RT, Fuchs BC. Noninvasive biomarkers of liver fibrosis: clinical applications and future directions. Curr Pathobiol Rep. 2014, 2:245-56. 10.1007\/s40139-014-0061-z","journal-title":"Curr Pathobiol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187033","article-title":"Etiology and mode of presentation of chronic liver diseases in India: A multi centric study","author":"Mukherjee PS","year":"2017","unstructured":"Mukherjee PS, Vishnubhatla S, Amarapurkar DN, et al.. Etiology and mode of presentation of chronic liver diseases in India: A multi centric study. 2017. 10.1371\/journal.pone.0187033"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227544","article-title":"Platelet indices significantly correlate with liver fibrosis in HCV-infected patients","author":"Shao LN","year":"2020","unstructured":"Shao LN, Zhang ST, Wang N, et al.. Platelet indices significantly correlate with liver fibrosis in HCV-infected patients. 2020. 10.1371\/journal.pone.0227544"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.10190","article-title":"FIB-4 and APRI scores for predicting severe fibrosis in chronic hepatitis C - a developing country's perspective in DAA era","volume":"12","author":"Karic U","year":"2018","unstructured":"Karic U, Pesic-Pavlovic I, Stevanovic G, et al.. FIB-4 and APRI scores for predicting severe fibrosis in chronic hepatitis C - a developing country's perspective in DAA era. J Infect Dev Ctries. 2018, 12:178-82. 10.3855\/jidc.10190","journal-title":"J Infect Dev Ctries"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-11-44","article-title":"A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI)","volume":"11","author":"Ahmad W","year":"2011","unstructured":"Ahmad W, Ijaz B, Javed FT, et al.. A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI). BMC Gastroenterol. 2011, 11:44. 10.1186\/1471-230X-11-44","journal-title":"BMC Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0012.0916","article-title":"New insights about albumin and liver disease","volume":"17","author":"Carvalho JR","year":"2018","unstructured":"Carvalho JR, Verdelho Machado M. New insights about albumin and liver disease. Ann Hepatol. 2018, 17:547-60. 10.5604\/01.3001.0012.0916","journal-title":"Ann Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/229304-a-comparative-study-of-novel-fibrosis-index-and-other-non-invasive-serum-indices-for-predicting-fibrosis-in-patients-of-chronic-liver-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T11:57:43Z","timestamp":1719921463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/229304-a-comparative-study-of-novel-fibrosis-index-and-other-non-invasive-serum-indices-for-predicting-fibrosis-in-patients-of-chronic-liver-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.63658","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,2]]}}}